Search clinical trials for: OSI-906

Total 2670 results

Sohag University

Not yet recruiting

Prevalence of Stuttering in Children With ADHD at Sohag University Hospital

ADHD Children With Stuttering

Egypt
University Hospital, Grenoble
AGIR à Dom

Unknown

Evaluation of Sleep Apnea and Cardiac Rhythm Abnormalities After Surgery Under General Anesthesia (Etude3A)

Obstructive Sleep Apnea | Arrhythmia
University of California, San Francisco
National Institutes of Health (NIH)

Completed

Measuring Effectiveness in Sleep Apnea Surgery

Obstructive Sleep Apnea

United States
COUR Pharmaceutical Development Company, Inc.

Not yet recruiting

Evaluate the Safety, Tolerability, Pharmacodynamics and Efficacy of CNP-106 in Subjects With Myasthenia Gravis

Myasthenia Gravis | Generalized Myasthenia | AChR Myasthenia Gravis | MuSK MG

United States
Avalo Therapeutics, Inc.

Withdrawn

A Pharmacokinetic, Pharmacodynamic, Safety and Tolerability Study of CERC-006 in Adults With Complex Lymphatic Malformations

Lymphatic Malformation

United States
Veloce BioPharma LLC

Completed

A Trial to Evaluate the Efficacy and Safety of Two Concentrations of VBP-926 Solution for the Treatment of Chemotherapy-associated Paronychia in Cancer Patients

Chemotherapy-Associated Paronychia

United States
AbbVie (prior sponsor, Abbott)

Completed

An Evaluation of the Biodistribution and Imaging Characteristics of ABT-806i (111In-ABT-806) in Subjects With Advanced Solid Tumor Types

Advanced Solid Tumors

Australia
Pfizer

Completed

Long-Term Open-Label Extension Trial for Subjects Completing the Phase 3 Trial of Fesoterodine (SP583) for the Treatment of Overactive Bladder Syndrome

Overactive Bladder Syndrome

Germany
Pfizer

Completed

A Multicenter Trial to Investigate Fesoterodine Sustained Release in Overactive Bladder Syndrome

Overactive Bladder Syndrome

Germany
Sixth Affiliated Hospital, Sun Yat-sen University

Recruiting

Safety and Efficacy of PD-1 ± mFOLFOX6 Neoadjuvant Therapy in Local Advanced sMPCC

Colorectal Cancer | Multiple Cancer

China
Fox Chase Cancer Center
Millennium Pharmaceuticals, Inc.

Terminated

Study to Assess Safety and Tolerability of MLN8237, In Combination With Erlotinib to Treat Non-Small Cell Lung Cancer

Non-small Cell Lung Cancer Metastatic | Non-small Cell Lung Cancer Recurrent

United States
M.D. Anderson Cancer Center
Genentech, Inc.; Aventis Pharmaceuticals

Completed

Erlotinib and Docetaxel With Concomitant Boost Radiation Therapy (XRT) for Head and Neck Squamous Cell Carcinoma (HNSCC)

Head and Neck Cancer

United States
National Cancer Institute (NCI)

Terminated

Erlotinib in Treating Patients With Stage I-IIIA Non-Small Cell Lung Cancer Undergoing Surgical Resection

Stage IIIA Non-small Cell Lung Cancer | Stage IA Non-small Cell Lung Cancer | Stage IB Non-small Cell Lung Cancer | Stage IIA Non-small Cell Lung Cancer | Stage IIB Non-small Cell Lung Cancer

United States
National Cancer Institute (NCI)

Completed

MK2206 and Erlotinib Hydrochloride in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Have Progressed After Previous Response to Erlotinib Hydrochloride Therapy

Lung Adenocarcinoma | Recurrent Non-Small Cell Lung Carcinoma | Adenosquamous Lung Carcinoma | Bronchioloalveolar Carcinoma | Large Cell Lung Carcinoma | Squamous Cell Lung Carcinoma

United States
Bayer

Completed

Hepatocellular Carcinoma - Advanced Stage - Sorafenib Trial in Taiwanese Patients (HATT)

Hepatocellular Carcinoma

Taiwan
Aeras
Sanofi Pasteur, a Sanofi Company

Completed

A Study for Safety and Immunogenicity of BCG and AERAS-404 in HIV-Negative, TB-Negative, BCG-Naive Adults (C-013-404)

Tuberculosis

Switzerland
Seikagaku Corporation

Completed

PK and Safety of SI-722 in IC/BPS

Interstitial Cystitis | Bladder Pain Syndrome

United States
selectION Therapeutics GmbH
FGK Clinical Research GmbH

Completed

A First-In-Human Study to Evaluate the Safety, Tolerability, and Efficacy of Si-544 in Adults With Atopic Dermatitis

Atopic Dermatitis

Germany
Seikagaku Corporation

Completed

SI-6603 Versus Placebo in Patients With Lumbar Disc Herniation

Lumbar Vertebra Hernia

Japan
Visco Vision Inc.

Completed

Clinical Performance of the OxyAqua Daily Disposable Silicone Hydrogel Soft Contact Lens

Myopia
University of California, Irvine
National Institute of General Medical Sciences (NIGMS)

Recruiting

Ability of Modulated Imaging and Laser Speckle Imaging to Determine Burn Wound Severity and Healing Potential

Skin Burn Multiple

United States
Bandim Health Project
Odense University Hospital; Odense Patient Data Explorative Network; Municipality...

Completed

Using BCG to Protect Senior Citizens During the COVID-19 Pandemic

Covid19 | Immunosenescence | Vaccine Preventable Disease | Morbidity | Non-specific Effects of Vaccines | Heterologous Immunity

Denmark
University of Oklahoma

Completed

The Effect of Ocular Rinse Volume on Surface Irritation After Intravitreal Injections

Age-Related Macular Degeneration | Diabetic Macular Edema | Intravitreal Injection | Ocular Rinse | Cystoid Macular Edema

United States
Megan Kruse, MD
AnHeart Therapeutics Inc.

Not yet recruiting

Taletrectinib in Previously Treated Metastatic CDH1-mutated Invasive Lobular Cancer (ILC)

Breast Cancer | Metastatic Breast Cancer

United States
ImmunityBio, Inc.

Completed

Phase 1b Study to Investigate the Safety and Maximum Tolerated Dose of Aldoxorubicin (INNO-206) Plus Doxorubicin HCL in Subjects With Advanced Solid Tumors

Advanced Solid Tumor

United States
Urovant Sciences GmbH
Ion Channel Innovations

Completed

Phase 1 Study With OAB Assessing the Safety and Activity of hMaxi-K Gene Transfer (OAB)

Overactive Bladder

United States
College of Charleston

Completed

Investigation of the Role of 905-nm Laser Light in the Delay of Muscle Fatigue

Muscle Fatigue

United States
9 Meters Biopharma, Inc.

Completed

Study of the Efficacy of Larazotide Acetate to Treat Celiac Disease

Celiac Disease

Canada, United States
Dartmouth-Hitchcock Medical Center
Aeras

Completed

Phase I Trial of DAR-901

Tuberculosis

United States
Cyberonics, Inc.
PRA Health Sciences

Completed

Seizure Detection and Automatic Magnet Mode Performance Study (E-36)

Epilepsy

Norway, Germany, United Kingdom, Belgium, Netherlands
Taejoon Pharmaceutical Co., Ltd.

Active, not recruiting

A Phase 3 Clinical Trials for Bowel Preparation for Colonoscopy

Bowel Preparation

Korea, Republic of
University of Arkansas

Completed

Maximizing the Dietary Pattern of Older Adults: the Effects of Protein Intake on Protein Kinetics

Sarcopenia

United States
National Cancer Institute (NCI)

Completed

Erlotinib in Treating Patients With Unresectable Liver Cancer and Liver Dysfunction

Advanced Adult Primary Liver Cancer | Localized Unresectable Adult Primary Liver Cancer | Recurrent Adult Primary Liver Cancer | Adult Primary Hepatocellular Carcinoma

United States
OSI Pharmaceuticals

Terminated

Erlotinib Versus Oral Etoposide in Patients With Recurrent or Refractory Pediatric Ependymoma (PETEY)

Recurrent or Refractory Pediatric Ependymoma

United States, Canada, United Kingdom
M.D. Anderson Cancer Center

Completed

Erlotinib in Combination With Cetuximab

Advanced Cancers

United States
University of Calgary

Unknown

HoloStream Study - Video Capture Device Usage (Holo-Stream)

Fistula | Central Venous Catheter Thrombosis | Nephrostomy; Complications
OHSU Knight Cancer Institute
National Cancer Institute (NCI); Oregon Health and Science University

Completed

Hyperspectral Endoscopy Imaging for the Early Detection of Precancerous Lesions in Average Risk Patients

Patient

United States
Statens Serum Institut

Completed

A Trial of the C-Tb Skin Test, When Given Intradermally to Adult Patients Recently Diagnosed With Active Tuberculosis (TB) (TESEC-04)

Tuberculosis

South Africa
ImmunityBio, Inc.

Completed

A Study to Investigate ALDOXORUBICIN in HIV-infected Subjects With Kaposi's Sarcoma

Kaposi's Sarcoma | AIDS | HIV Positive

United States
Corvus Pharmaceuticals, Inc.

Completed

Study of CPI-006 as Immunotherapy for Hospitalized COVID-19 Patients

COVID-19

United States
Dartmouth-Hitchcock Medical Center
Muhimbili University of Health and Allied Sciences

Completed

DAR-901 TB Booster Vaccine to Prevent TB in Adolescents (DAR-PIA)

Tuberculosis

Tanzania
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Drug Interaction Between Multiple Doses of Ketoconazole and a Single Dose of SKI-606

Healthy

United States
Sichuan Baili Pharmaceutical Co., Ltd.

Recruiting

A Study of SI-B003 and BL-B01D1+SI-B003 in Patients With Locally Advanced or Metastatic Esophageal Cancer, Gastric Cancer, Colorectal Cancer and Other Gastrointestinal Tumors

Gastric Cancer | Colorectal Cancer | Esophageal Cancer

China
Sichuan Baili Pharmaceutical Co., Ltd.

Recruiting

A Study of SI-B003 and BL-B01D1+SI-B003 in Patients With Locally Advanced or Metastatic Urothelial Carcinoma and Other Solid Tumors

Solid Tumor | Urothelial Carcinoma

China
Seikagaku Corporation

Completed

SI-6603 (Condoliase) Study for Lumbar Disc Herniation (Discovery 6603 Study)

Lumbar Disc Herniation

United States
University Hospital, Montpellier
European Regional Development Fund; DMS Apelem; BPIfrance; Thales; Digisens; Medecom

Unknown

Value of Tomosynthesis for the Detection of Sacro-iliitis (TOMOS SI) (TOMOS SI)

Sacroiliitis

France
Abion Inc

Completed

To Evaluate the Safety, Pharmacokinetic and the Effect of Food After Administration of ABN401 in Healthy Adult Volunteers

Solid Tumor

Korea, Republic of
ImmunityBio, Inc.

Completed

Phase 2 Study to Investigate the Efficacy and Safety of Aldoxorubicin in Subjects With Glioblastoma

Glioblastoma

United States
Galapagos NV

Terminated

A Study to Assess Efficacy, Safety, Tolerability and Pharmacokinetics (PK)/Pharmacodynamics (PD) of MOR106 in Subjects With Moderate to Severe Atopic Dermatitis (IGUANA)

Atopic Dermatitis

Germany, Hungary, Poland, Slovakia, United Kingdom
Pfizer

Completed

Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias

Chronic Myeloid Leukemia

United States, Spain, Australia, Canada, Hong Kong, Singapore, United Kingdom, Germany, Netherlands, Chile, India, South Africa, Sweden, Peru, Argentina, Italy, Austria, Colombia, Brazil, China, Finland, Hungary, Korea, Republic of, M... and more

Search clinical trials for: OSI-906

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Argentina

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations